Press coverage about CME Group (NASDAQ:CME) has trended somewhat positive this week, Accern reports. The research group identifies positive and negative news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. CME Group earned a media sentiment score of 0.19 on Accern’s scale. Accern also gave press coverage about the financial services provider an impact score of 47.161393056295 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
These are some of the news stories that may have effected Accern Sentiment Analysis’s scoring:
- $1.03 Billion in Sales Expected for CME Group (CME) This Quarter (americanbankingnews.com)
- CME Group’s expanding global reach is key factor in growth of market share (metalbulletin.com)
- Nex shareholders vote in favour of CME deal (ft.com)
- CME Group (CME) Expected to Post Earnings of $1.68 Per Share (americanbankingnews.com)
- CME Group Says It’s Gauging Client Interest on Ethereum Futures After Index Launch (coinspeaker.com)
A number of equities research analysts have recently issued reports on CME shares. ValuEngine upgraded CME Group from a “hold” rating to a “buy” rating in a report on Monday, April 2nd. Goldman Sachs upgraded CME Group from a “neutral” rating to a “buy” rating and set a $180.00 price objective for the company in a report on Wednesday, February 7th. BidaskClub cut CME Group from a “strong-buy” rating to a “buy” rating in a report on Thursday, March 15th. Bank of America boosted their price objective on CME Group from $175.00 to $185.00 and gave the stock a “buy” rating in a report on Thursday, March 8th. Finally, Sandler O’Neill restated a “buy” rating and set a $175.00 price objective on shares of CME Group in a report on Friday, February 2nd. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. CME Group currently has a consensus rating of “Buy” and a consensus price target of $165.57.
Shares of CME Group traded up $1.60, reaching $161.38, during midday trading on Monday, according to Marketbeat. The company’s stock had a trading volume of 980,293 shares, compared to its average volume of 1,692,104. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.10. CME Group has a fifty-two week low of $116.35 and a fifty-two week high of $171.71. The company has a market cap of $54.24 billion, a price-to-earnings ratio of 33.83, a PEG ratio of 2.24 and a beta of 0.57.
CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, April 26th. The financial services provider reported $1.86 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.01. CME Group had a net margin of 111.45% and a return on equity of 8.48%. The company had revenue of $1.10 billion during the quarter, compared to the consensus estimate of $1.12 billion. During the same period in the previous year, the business earned $1.22 earnings per share. The firm’s quarterly revenue was up 18.4% on a year-over-year basis. equities research analysts forecast that CME Group will post 6.79 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 25th. Shareholders of record on Friday, June 8th will be given a dividend of $0.70 per share. The ex-dividend date of this dividend is Thursday, June 7th. This represents a $2.80 annualized dividend and a yield of 1.74%. CME Group’s dividend payout ratio is currently 58.70%.
In other CME Group news, insider Hilda Harris Piell sold 3,299 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $163.52, for a total transaction of $539,452.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction that occurred on Tuesday, April 10th. The shares were sold at an average price of $161.02, for a total transaction of $402,550.00. Following the transaction, the chief financial officer now owns 34,957 shares of the company’s stock, valued at $5,628,776.14. The disclosure for this sale can be found here. 0.45% of the stock is owned by insiders.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.